全文获取类型
收费全文 | 7430篇 |
免费 | 541篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 276篇 |
妇产科学 | 145篇 |
基础医学 | 1401篇 |
口腔科学 | 93篇 |
临床医学 | 818篇 |
内科学 | 1416篇 |
皮肤病学 | 255篇 |
神经病学 | 726篇 |
特种医学 | 175篇 |
外科学 | 864篇 |
综合类 | 52篇 |
一般理论 | 2篇 |
预防医学 | 389篇 |
眼科学 | 78篇 |
药学 | 446篇 |
中国医学 | 20篇 |
肿瘤学 | 808篇 |
出版年
2023年 | 41篇 |
2022年 | 59篇 |
2021年 | 102篇 |
2020年 | 96篇 |
2019年 | 126篇 |
2018年 | 155篇 |
2017年 | 121篇 |
2016年 | 149篇 |
2015年 | 170篇 |
2014年 | 194篇 |
2013年 | 300篇 |
2012年 | 498篇 |
2011年 | 534篇 |
2010年 | 286篇 |
2009年 | 306篇 |
2008年 | 482篇 |
2007年 | 560篇 |
2006年 | 488篇 |
2005年 | 518篇 |
2004年 | 482篇 |
2003年 | 458篇 |
2002年 | 420篇 |
2001年 | 93篇 |
2000年 | 69篇 |
1999年 | 90篇 |
1998年 | 88篇 |
1997年 | 88篇 |
1996年 | 77篇 |
1995年 | 72篇 |
1994年 | 68篇 |
1993年 | 49篇 |
1992年 | 52篇 |
1991年 | 53篇 |
1990年 | 50篇 |
1989年 | 47篇 |
1988年 | 58篇 |
1987年 | 50篇 |
1986年 | 30篇 |
1985年 | 33篇 |
1984年 | 33篇 |
1983年 | 35篇 |
1982年 | 32篇 |
1980年 | 24篇 |
1977年 | 21篇 |
1975年 | 20篇 |
1974年 | 20篇 |
1973年 | 24篇 |
1972年 | 19篇 |
1971年 | 18篇 |
1970年 | 18篇 |
排序方式: 共有7995条查询结果,搜索用时 15 毫秒
111.
112.
Esther Strauss David F. Hultsch Michael Hunter Daniel J. Slick Brigitte Patry Judi Levy-Bencheton 《The Clinical neuropsychologist》2013,27(4):420-432
The utility of measures for detecting malingering was evaluated using a simulation design in which half the participants were encouraged to do their best and half were asked to feign head injury. Particular attention was focused on the utility of repeated assessment (intraindividual variability) in discriminating the groups. Participants were tested on three occasions on measures commonly used to detect malingering including a specific symptom validity test (SVT). The results indicated that multiple measures of malingering obtained in single assessment (occasion one) discriminated the groups effectively. In addition, however, intraindividual variability in performance, particularly of indicators from the SVT, provided unique information beyond level of performance. The results suggest that response inconsistency across testing sessions may be a clinically useful measure for the detection of malingering. 相似文献
113.
Christine Levesque Frédéric Couture Anna Kwiatkowska Roxane Desjardins Brigitte Guérin Witold A. Neugebauer Robert Day 《Oncotarget》2015,6(6):3680-3693
Prostate cancer is the leading cancer in North American men. Current pharmacological treatments are limited to anti-androgen strategies and the development of new therapeutic approaches remains a challenge. As a fundamentally new approach, we propose the inhibition of PACE4, a member of the proprotein convertases family of enzymes, as a therapeutic target in prostate cancer. We developed an inhibitor named the Multi-Leu peptide, with potent in vitro anti-proliferative effects. However, the Multi-Leu peptide has not been tested under in vivo conditions and its potency under such conditions is most likely limited, due to the labile characteristics of peptides in general. Using a peptidomimetic approach, we modified the initial scaffold, generating the analog Ac-[DLeu]LLLRVK-Amba, which demonstrates increased inhibitory potency and stability. The systemic administration of this peptidomimetic significantly inhibits tumor progression in the LNCaP xenograft model of prostate cancer by inducing tumor cell quiescence, increased apoptosis and neovascularization impairment. Pharmacokinetic and biodistribution profiles of this inhibitor confirm adequate tumor delivery properties of the compound. We conclude that PACE4 peptidomimetic inhibitors could result in stable and potent drugs for a novel therapeutic strategy for prostate cancer. 相似文献
114.
115.
116.
117.
118.
Heymans Lothar Huber Martin Paeschke Norbert Palissa Harriet Keller-Stanislawski Brigitte 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2018,61(9):1088-1092
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Schulungsmaterial für Heilberufler und Patienten stellt eine wichtige Hilfe bei der sicheren Anwendung bestimmter... 相似文献
119.
120.
Obesity-induced insulin resistance has been linked to adipose tissue lipid aldehyde production and protein carbonylation. Trans-4-hydroxy-2-nonenal (4-HNE) is the most abundant lipid aldehyde in murine adipose tissue and is metabolized by glutathione S-transferase A4 (GSTA4), producing glutathionyl-HNE (GS-HNE) and its metabolite glutathionyl-1,4-dihydroxynonene (GS-DHN). The objective of this study was to evaluate adipocyte production of GS-HNE and GS-DHN and their effect on macrophage inflammation. Compared with lean controls, GS-HNE and GS-DHN were more abundant in visceral adipose tissue of ob/ob mice and diet-induced obese, insulin-resistant mice. High glucose and oxidative stress induced production of GS-HNE and GS-DHN by 3T3-L1 adipocytes in a GSTA4-dependent manner, and both glutathionylated metabolites induced secretion of tumor necrosis factor-α from RAW 264.7 and primary peritoneal macrophages. Targeted microarray analysis revealed GS-HNE and GS-DHN induced expression of inflammatory genes, including C3, C4b, c-Fos, igtb2, Nfkb1, and Nos2. Transgenic overexpression of GSTA4 in mouse adipose tissue led to increased production of GS-HNE associated with higher fasting glucose levels and moderately impaired glucose tolerance. These results indicated adipocyte oxidative stress results in GSTA4-dependent production of proinflammatory glutathione metabolites, GS-HNE and GS-DHN, which may represent a novel mechanism by which adipocyte dysfunction results in tissue inflammation and insulin resistance. 相似文献